Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › Immunology

Immunology (42 companies · 22 conditions)

Conditions

Systemic Lupus Erythematosus 14 Rheumatoid Arthritis 12 Systemic Sclerosis 9 Rare Idiopathic Inflammatory Myopathies 8 Rare Chronic Urticaria 6 Sjögren's Syndrome 5 Ulcerative Colitis 5 Crohn's Disease 4 Dermatomyositis 3 Rare Food Allergy 3 Psoriatic Arthritis 3 ANCA-Associated Vasculitis 2 Rare Axial Spondyloarthritis 2 Graves' Disease 2 IgG4-Related Disease 2 Rare Cow's Milk Allergy 1 Graft-versus-Host Disease 1 Rare Hereditary Angioedema 1 Rare Leukocyte Adhesion Deficiency-I 1 Rare Peanut Allergy 1 Primary Humoral Immunodeficiency 1 Rare Transplant Rejection 1 Rare

Companies

Ticker Company Therapeutic areas In Immunology Lead stage Programs
ACET Adicet Bio ImmunologyNeurology+2 Rare 4 Phase 1 8
ADMA Adma Biologics ImmunologyInfectious Disease Rare 2 Approved 4
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 4
ALLO Allogene Therapeutics ImmunologyOncology Rare 3 Phase 2 10
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 1 Approved 6
RCUS Arcus Biosciences DermatologyImmunology+1 1 Phase 3 6
ARTV Artiva Biotherapeutics DermatologyImmunology+2 Rare 6 Phase 2 14
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved 12
CABA Cabaletta Bio DermatologyImmunology+2 Rare 5 Phase 1 8
RNAC Cartesian Therapeutics ImmunologyNeurology+1 Rare 2 Phase 3 4
CLDX Celldex Therapeutics DermatologyImmunology+1 4 Phase 3 7
IPSC Century Therapeutics ImmunologyMetabolic+1 Rare 6 Phase 1 9
CLYM Climb Bio HematologyImmunology+1 Rare 2 Phase 2 7
CUE Cue Biopharma ImmunologyOncology 1 Phase 2 6
CGEM Cullinan Therapeutics HematologyImmunology+2 Rare 4 NDA Submitted 10
DBVT DBV Technologies Immunology 2 NDA Submitted 2
ELDN Eledon Pharmaceuticals ImmunologyNeurology Rare 1 Phase 2 2
ENTA Enanta Pharmaceuticals DermatologyImmunology+1 1 Phase 2 6
EVMN Evommune DermatologyImmunology+1 2 Phase 2 6
IMVT Immunovant ImmunologyNeurology Rare 4 Phase 3 6
INAB IN8bio ImmunologyOncology 1 Phase 2 6
IXHL Incannex Healthcare ImmunologyNeurology+1 1 Phase 2 3
NTLA Intellia Therapeutics CardiovascularImmunology Rare 1 NDA Submitted 3
JBIO Jade Biosciences ImmunologyRenal Rare 2 Phase 2 4
KYTX Kyverna Therapeutics ImmunologyNeurology+1 Rare 1 NDA Submitted 7
INKT MiNK Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 7
MLTX MoonLake Immunotherapeutics DermatologyImmunology Rare 2 Phase 3 4
NKTR Nektar Therapeutics DermatologyImmunology+2 1 Phase 3 11
NKTX Nkarta ImmunologyNeurology+1 Rare 5 Phase 1 8
NRIX Nurix Therapeutics ImmunologyNeurology+1 1 Phase 3 16
ORKA Oruka Therapeutics DermatologyImmunology Rare 1 Phase 2 7
PALI Palisade Bio Immunology 2 Phase 1 3
PCSA Processa Pharmaceuticals GI/HepatologyImmunology+2 Rare 2 Phase 2 7
QNRX Quoin Pharmaceuticals DermatologyImmunology Rare 1 Phase 2 4
RCKT Rocket Pharmaceuticals CardiovascularImmunology Rare 1 Approved 4
SYRE Spyre Therapeutics DermatologyImmunology Rare 12 Phase 2 13
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved 29
VRDN Viridian Therapeutics ImmunologyOphthalmology 1 Approved 5
VOR Vor Biopharma ImmunologyNeurology Rare 1 Phase 3 2
XNCR Xencor HematologyImmunology+4 Rare 10 Approved 36
ZBIO Zenas BioPharma DermatologyImmunology+2 Rare 3 NDA Submitted 11
ZURA Zura Bio DermatologyImmunology Rare 1 Phase 2 5